|
USP10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.641400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.574200E-01 |
| Normal-vs-Stage2 |
5.158200E-01 |
| Normal-vs-Stage3 |
1.424430E-01 |
| Normal-vs-Stage4 |
3.379800E-01 |
| Stage1-vs-Stage2 |
4.345000E-01 |
| Stage1-vs-Stage3 |
6.248200E-02 |
| Stage1-vs-Stage4 |
3.333400E-01 |
| Stage2-vs-Stage3 |
4.794000E-02 |
| Stage2-vs-Stage4 |
1.556970E-01 |
| Stage3-vs-Stage4 |
6.633400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.287200E-01 |
| Normal-vs-AfricanAmerican |
3.105000E-01 |
| Normal-vs-Asian |
4.279200E-01 |
| Caucasian-vs-AfricanAmerican |
1.322410E-01 |
| Caucasian-vs-Asian |
7.211200E-01 |
| AfricanAmerican-vs-Asian |
1.353010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.676800E-01 |
| Normal-vs-Female |
7.516600E-01 |
| Male-vs-Female |
6.600400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.830600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.293600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.440200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.392200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.864000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.849600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.295000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.224400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.617200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.991000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.584400E-01 |
| Classical-VS-Follicular |
2.313800E-01 |
| Classical-VS-Other |
3.222200E-01 |
| Classical-VS-Normal |
8.036200E-01 |
| Tall-VS-Follicular |
8.198400E-01 |
| Tall-VS-Other |
6.623600E-01 |
| Tall-VS-Normal |
3.563000E-01 |
| Follicular-VS-Other |
6.573400E-01 |
| Follicular-VS-Normal |
4.509000E-01 |
| Other-VS-Normal |
3.266000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.911000E-01 |
| Normal-vs-N1 |
1.742090E-02 |
| N0-vs-N1 |
5.167900E-02 |
|
|
